News & Events

Somin Lee and her research group developed a way to reduce trial and error in gene editing by getting a look at the process in real time.

Polyurethane locks in the antimicrobial power of tea tree and cinnamon oils. The new technology could start making public spaces safer within a year.

We are pleased to announce the funding selections for the MNI-BI 2022 Neuroregeneration and Cognition Challenge seed fund competition.

Congratulations to the 2022 BI Innovator Award Recipients. BI Innovator awards recognize members of the BI research community who are active participants in the research, innovation and translational ecosystem at BI and making a difference in our community.

BI welcomes Carl Gordon and Natasha Shervani of OrbiMed as new members of its External Advisory Board.

Sharon Glotzer has received the Vannevar Bush Faculty Fellowship from the U.S. Department of Defense, becoming one of nine distinguished faculty scientists and engineers to receive the award this year.

Lola Eniola-Adefeso is part of an international research team that recently received $7.5 million from the Leducq Foundation for their AntheroGEN project.

Joerg Lahann and Colin Greineder are part of the research team that received funding from the NIH to study a new nanomedicine that crosses the blood-brain barrier, engages the immune system and kills cancer cells may offer hope for treating the most aggressive form of brain cancer, glioblastoma.

A new study from the Schwendeman lab describes one of the first entirely new drug delivery microencapsulation approaches in decades.

Developed in the VanEpps and Kotov labs, a new machine learning model that predicts interactions between nanoparticles and proteins.

Nick Kotov was named to the American Academy of Arts and Sciences for his significant contributions in scholarly and professional fields.

Collaborative research in the Aguilar lab showed how two of the body’s natural injury responders conflict following traumatic muscle injuries.

Congratulations to Even Keller on joining OVPR as the inaugural Director of Research Cores.

The collaboration developed a new photonic effect which could speed up the development of new antibiotics and drugs through automation.

The Biointerfaces Institute is pleased to welcome our Inaugural Innovation Fellows, Dr. Anastasia Visheratina and Dr. Dylan Neale.